

ÆÃ¡¡½¸
Æü¡¹ÊѲ½¤¹¤ë¿··¿¥³¥í¥Ê¥¦¥¤¥ë¥¹´¶À÷¾É¤È¤½¤Î´ÉÍý
Æü¡¹ÊѲ½¤¹¤ë¿··¿¥³¥í¥Ê¥¦¥¤¥ë¥¹´¶À÷¾É¤È¤½¤Î´ÉÍý
ÆÃ½¸¤Ë¤¢¤¿¤Ã¤Æ
ÃÓÅÄ¡¡¼÷¾¼
ȯ¾Éµ¡½ø¤È½Å¾É²½¤Î¥á¥«¥Ë¥º¥à¤Ë¤Ä¤¤¤Æ
µÜÆâ¡¡À¶»Ê¡¦ÃæÅÄ¡¡¹§ÌÀ
¿··¿¥³¥í¥Ê¥¦¥¤¥ë¥¹¤ÎÊѰ۳ô¤Ë¤Ä¤¤¤Æ
¿Àë¡¡¡¡ÏË
COVID-19 ¤Î½Å¾É²½Í½Â¬¥Þ¡¼¥«¡¼¤Î³«È¯¤ÈÎ×¾²±þÍÑ
¿ù»³¡¡¿¿Ìé
COVID-19 ¼£ÎŤΠoverview¡¨¤³¤ì¤Þ¤Ç¤È¤³¤ì¤«¤é¡¤¤½¤ÎÁ°¤Ë
Ê¿°æ¡¡Í³»ù
SARS-CoV-2 ¤È¥ï¥¯¥Á¥ó
ÂÀÅÄ¡¡¸¼£¡¦ú˸¶¡¡¹îµª
COVID-19 ¤È ECMO
ÀÐÁÒ¡¡¹¨¶³¡¦À±Ìî¡¡¹ÌÂç
SARS-CoV-2 ¤È ·ì±Õ¾ô²½ÎÅË¡¤Î²ÄǽÀ
ÊÒ¶Í¡¡ÂçÊå
ÃÓÅÄ¡¡¼÷¾¼
ȯ¾Éµ¡½ø¤È½Å¾É²½¤Î¥á¥«¥Ë¥º¥à¤Ë¤Ä¤¤¤Æ
µÜÆâ¡¡À¶»Ê¡¦ÃæÅÄ¡¡¹§ÌÀ
¿··¿¥³¥í¥Ê¥¦¥¤¥ë¥¹¤ÎÊѰ۳ô¤Ë¤Ä¤¤¤Æ
¿Àë¡¡¡¡ÏË
COVID-19 ¤Î½Å¾É²½Í½Â¬¥Þ¡¼¥«¡¼¤Î³«È¯¤ÈÎ×¾²±þÍÑ
¿ù»³¡¡¿¿Ìé
COVID-19 ¼£ÎŤΠoverview¡¨¤³¤ì¤Þ¤Ç¤È¤³¤ì¤«¤é¡¤¤½¤ÎÁ°¤Ë
Ê¿°æ¡¡Í³»ù
SARS-CoV-2 ¤È¥ï¥¯¥Á¥ó
ÂÀÅÄ¡¡¸¼£¡¦ú˸¶¡¡¹îµª
COVID-19 ¤È ECMO
ÀÐÁÒ¡¡¹¨¶³¡¦À±Ìî¡¡¹ÌÂç
SARS-CoV-2 ¤È ·ì±Õ¾ô²½ÎÅË¡¤Î²ÄǽÀ
ÊÒ¶Í¡¡ÂçÊå
¾É¡¡Îã
¹â¸úΨ»ý³·ì±Õ¤í²áÆ©ÀϤò bridge therapy ¤È¤·¤Æ»Ü¹Ô¤·¡¤¹Ò¶õÈÂÁ÷¤È°Ü¿¢¤ËÀ®¸ù
¤·¤¿Æý»ùµÞÀ´ÎÉÔÁ´¤Î1¾ÉÎã
¾®³Þ¸¶½ç»Ò¡¦¸åÆ£¡¡¡¡É𡦻³ÅÄ¡¡Âçµ®¡¦ÎëÌÚ¡¡Íµ¼ù
º´Æ£¡¡ÃÎɧ¡¦¶¶¾ì¡¡±ÑÆó¡¦×¢ÅÄ¡¡ÏÂÈþ
¤·¤¿Æý»ùµÞÀ´ÎÉÔÁ´¤Î1¾ÉÎã
¾®³Þ¸¶½ç»Ò¡¦¸åÆ£¡¡¡¡É𡦻³ÅÄ¡¡Âçµ®¡¦ÎëÌÚ¡¡Íµ¼ù
º´Æ£¡¡ÃÎɧ¡¦¶¶¾ì¡¡±ÑÆó¡¦×¢ÅÄ¡¡ÏÂÈþ
